ARCHIVED PRESS RELEASES

Humanigen Appoints Chief Financial Officer

August 28, 2017

Humanigen Announces up to $15 Million Committed Equity Financing Facility

August 24, 2017

Humanigen CEO Receives PharmaVOICE 100 Red Jacket Award

August 11, 2017

Humanigen Announces Completion of Benznidazole Bioavailability Study

August 8, 2017

Humanigen, Inc. Is Effective Today

August 7, 2017

KaloBios To Change Company Name To Humanigen, Inc.

July 27, 2017

KaloBios Receives $5.0M in New Funding Commitment From Existing Investors

July 12, 2017

KaloBios Receives Orphan Drug Designation for Benznidazole in the Treatment of Chagas Disease

July 11, 2017

Benznidazole IND for Chagas Disease Receives Clearance by FDA

June 27, 2017

KaloBios Upgrades Stock to OTCQB Market

June 26, 2017

©2019 Humanigen, Inc.  All rights reserved